conference center.

Gilenya Research and Trials

Dr. Daniel Kantor 02/24/2016

Dr. Daniel Kantor talks with Dr. Daniel Wynn, Director of Clinical Research and Director of the MS Center at Consultants in Neurology at Chicago, IL about current research and trials on Gilenya.

Leave a Reply

Your email address will not be published. Required fields are marked *

We Thank Biogen, Mylan, Novartis, Genentech and Mallinckrodt for supporting MSWorld's coverage of ACTRIMS 2016.
We also Thank Biogen, EMD Serono, Mylan, Novartis, Teva, Genentech, Sanofi-Genzyme, Acorda and Mallinckrodt for supporting MSWorld's Overall 2016 Conference Coverage Program.

Information shared here is not for the diagnosis or treatment of any medical condition. For specific information and advice, consult your personal physician.
×
×

Leaving MSWorld.org

Words to explain why you're leaving

×